Day: June 28, 2021

Webinar Event to Be Held Tomorrow June 29th at 12pm Eastern / 9am Pacific Time SAN DIEGO, CA, June 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and other life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome, announced today that its Chairman and CEO, Jim Joyce will participate in a webinar entitled: “The Evolution of Blood Purification Technologies to Treat Emerging Pandemic Threats, Including COVID-19.”  The event will be held tomorrow at 12pm eastern. Event registration can be accessed through the following link: https://forcewealth.com/portfolio-items/sigyn-06-29/?portfolioCats=28 Prompted by 911 and the October 2001 Anthrax attacks, the industry to support the development of drug and vaccine...

CINCINNATI, June 28, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has re-submitted its application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for the company’s SARS-CoV-2 molecular diagnostic test on the Revogene® platform. On February 22, 2021, Meridian voluntarily withdrew its EUA application in order to conduct additional studies based on guidance from the FDA. Meridian completed the additional studies and re-submitted its EUA application on Friday, June 25, 2021. Tony Serafini-Lamanna, Executive Vice President – Diagnostics, said, “We are pleased to have completed these studies and resubmitted our EUA application. We look forward to the FDA’s review of the Revogene...

The conversion price represents a premium to market CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, is pleased to announce that Mr. Greg Siokas, Chief Executive Officer, has reduced the debt of the Company by converting $3.0 million of related party debt personally owed to him in exchange for 500,000 shares of common stock at $6.00 per share on June 25, 2021. The conversion price represents a premium to the previous day’s closing price and is a direct reflection of the commitment of the CEO to the long-term objective of building a diversified pharmaceutical company with an established...

WEST PALM BEACH, Fla., June 28, 2021 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, is please to confirm it has closed the agreement with VisualMED Clinical Solutions Corp. (VisualMED) a Nevada based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into VisualMED. These entities will operate as wholly owned subsidiaries of VisualMED which will immediately take the steps required to complete a name and trading symbol change. VisualMED intends to complete the required filings to become compliant with SEC reporting requirements to become a fully reporting company as soon as practical. Rennova...

TORONTO, June 28, 2021 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSXV: DSV; OTCQX: DSVSF) (“Discovery” or “the Company”) is pleased to announce the results of voting at its Annual General Meeting held Friday, June 25, 2021. Shareholders voted in favour of all items put forward by the Board of Directors (“the Board”) and Management. Shareholders voted in favour of the election of all director nominees: Murray John (Chair); Taj Singh; Mark O’Dea; Jeff Parr; Moira Smith; Daniel Vickerman; and Jennifer Wagner. Mr. Vic Chevillon and Mr. Jesus Hernandez-Garza did not stand for re-election for the ensuing year. Taj Singh, President and CEO states: “Discovery would like to thank both Vic and Jesus for their contributions to our success over their tenure and we look forward to working with them as advisors to the Company. On behalf of...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 28, 2021 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault”) (SVI-TSX-V) is pleased to announce that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) led by Scotiabank and CIBC Capital Markets as Joint Bookrunners, under which the Underwriters have agreed to purchase $50 million aggregate principal amount of listed senior unsecured hybrid debentures due September 30, 2026 (the “Debentures”) at a price of $1,000 per Debenture (the “Offering”). StorageVault has also granted the underwriters an option to purchase up to an additional $7.5 million aggregate principal amount of Debentures, on the same terms and conditions, exercisable in whole or in part, for a period of 30 days...